ArticleWiener klinische Wochenschrift2020

Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk.

Markus C Stühlinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.